$TWST
Twist Bioscience Corp Stock $twst

$twst Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024034434 Filed on August 02, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue		$81.46M	$63.74M
YoY Change		27.81%	13.59%
Cost Of Revenue		$46.19M	$41.85M
YoY Change		10.39%	35.1%
Gross Profit		$35.27M	$21.90M
YoY Change		61.09%	-12.9%
Gross Profit Margin		43.3%	34.35%
Selling, General & Admin		$56.79M	$46.06M
YoY Change		23.31%	-14.22%
% of Gross Profit		161.02%	210.35%
Research & Development		$22.47M	$24.53M
YoY Change		-8.39%	-33.42%
% of Gross Profit		63.7%	112.03%
Depreciation & Amortization		$7.000M	$8.490M
YoY Change		-17.55%	91.04%
% of Gross Profit		19.85%	38.78%
Operating Expenses		$79.26M	$70.59M
YoY Change		12.29%	-22.03%
Operating Profit		-$88.92M	-$48.69M
YoY Change		82.63%	-20.39%
Interest Expense		$3.663M	$3.967M
YoY Change		-7.66%
% of Operating Profit
Other Income/Expense, Net		-$121.0K	$41.00K
YoY Change		-395.12%	-118.22%
Pretax Income		-$85.38M	-$56.77M
YoY Change		50.39%	-6.42%
Income Tax		$200.0K	$622.0K
% Of Pretax Income
Net Earnings		-$85.57M	-$57.40M
YoY Change		49.09%	-5.16%
Net Earnings / Revenue		-105.04%	-90.05%
Basic Earnings Per Share		-$1.47	-$1.01
Diluted Earnings Per Share		-$1.47	-$1.01
COMMON SHARES
Basic Shares Outstanding	58.59M shares	58.23M shares	57.15M shares
Diluted Shares Outstanding		58.15M shares	57.04M shares

Balance Sheet

Concept	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$289.4M	$357.1M
YoY Change	-18.96%	-32.31%
Cash & Equivalents	$239.1M	$307.5M
Short-Term Investments	$50.28M	$49.69M
Other Short-Term Assets	$11.94M	$9.458M
YoY Change	26.25%	-23.16%
Inventory	$28.48M	$36.35M
Prepaid Expenses
Receivables	$31.99M	$37.01M
Other Receivables	$0.00	$5.569M
Total Short-Term Assets	$361.8M	$445.5M
YoY Change	-18.79%	-28.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$106.3M	$212.8M
YoY Change	-50.03%	67.55%
Goodwill	$85.81M	$85.81M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.224M	$10.40M
YoY Change	-49.78%	168.67%
Total Long-Term Assets	$276.3M	$364.8M
YoY Change	-24.26%	2.6%
TOTAL ASSETS
Total Short-Term Assets	$361.8M	$445.5M
Total Long-Term Assets	$276.3M	$364.8M
Total Assets	$638.1M	$810.3M
YoY Change	-21.25%	-17.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.626M	$12.18M
YoY Change	-45.62%	-42.02%
Accrued Expenses	$14.84M	$50.73M
YoY Change	-70.75%	434.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$73.76M	$72.82M
YoY Change	1.28%	-21.43%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$597.0K	$79.96M
YoY Change	-99.25%	3789.11%
Total Long-Term Liabilities	$597.0K	$79.96M
YoY Change	-99.25%	3789.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.76M	$72.82M
Total Long-Term Liabilities	$597.0K	$79.96M
Total Liabilities	$147.0M	$152.8M
YoY Change	-3.8%	-3.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.207B	-$986.8M
YoY Change	22.34%	26.95%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$491.1M	$657.6M
YoY Change
Total Liabilities & Shareholders Equity	$638.1M	$810.3M
YoY Change	-21.25%	-17.28%

Cashflow Statement

Concept	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$85.57M	-$57.40M
YoY Change	49.09%	-5.16%
Depreciation, Depletion And Amortization	$7.000M	$8.490M
YoY Change	-17.55%	91.04%
Cash From Operating Activities	-$6.378M	-$23.41M
YoY Change	-72.76%	-31.39%
INVESTING ACTIVITIES
Capital Expenditures	$965.0K	$4.509M
YoY Change	-78.6%	-111.09%
Acquisitions
YoY Change
Other Investing Activities	$254.0K	$23.18M
YoY Change	-98.9%	-48.27%
Cash From Investing Activities	-$711.0K	$18.67M
YoY Change	-103.81%	348.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.908M	-661.0K
YoY Change	-539.94%	-49.58%
NET CHANGE
Cash From Operating Activities	-6.378M	-23.41M
Cash From Investing Activities	-711.0K	18.67M
Cash From Financing Activities	2.908M	-661.0K
Net Change In Cash	-4.181M	-5.403M
YoY Change	-22.62%	-82.72%
FREE CASH FLOW
Cash From Operating Activities	-$6.378M	-$23.41M
Capital Expenditures	$965.0K	$4.509M
Free Cash Flow	-$7.343M	-$27.92M
YoY Change	-73.7%	-528.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001581280
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Twist Bioscience Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2058888
	dei	Entity Address Address Line1 EntityAddressAddressLine1	681 Gateway Blvd
	dei	Entity Address City Or Town EntityAddressCityOrTown	South San Francisco
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94080
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	719-0671
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	TWST
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58585960	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239142000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286470000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	50276000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	49943000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31988000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44064000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	28484000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	32063000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11941000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	361831000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	424256000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106339000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131830000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61277000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	71531000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	85811000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	85811000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14741000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54483000	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2895000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2811000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5224000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5681000	usd
CY2024Q2	us-gaap	Assets Assets	638118000	usd
CY2023Q3	us-gaap	Assets Assets	776403000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6626000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	14052000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14838000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10754000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25818000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14555000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14896000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6079000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7803000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	73757000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57557000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57557000	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1699127000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1657222000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-735000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-756000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1207253000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1033034000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	491139000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	623432000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	638118000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	776403000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	81464000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	63740000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	228264000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	178163000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	46193000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	41845000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	133148000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	112956000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22469000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24528000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	69718000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	83148000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	56794000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46057000	usd
CY2024Q2	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q2	us-gaap	Restructuring Costs RestructuringCosts	9052000	usd
	us-gaap	Restructuring Costs RestructuringCosts	0	usd
	us-gaap	Restructuring Costs RestructuringCosts	9052000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58145000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58145000	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1195000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19016000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1208000	usd
	us-gaap	Profit Loss ProfitLoss	-158375000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	657550000	usd
	us-gaap	Profit Loss ProfitLoss	-174071000	usd
	us-gaap	Profit Loss ProfitLoss	-158375000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24776000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20810000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	81464000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	63740000	usd
	twst	Change In Fair Value Of Contingent Consideration And Indemnity Holdback ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback	5913000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	124521000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	413052000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	345210000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-88922000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-60781000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-184788000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3663000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3968000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-121000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	41000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-351000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-85380000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-56773000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	191000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3967000	usd
	twst	Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan	2047000	usd
	dei	Entity File Number EntityFileNumber	001-38720
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11716000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	31659000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	73323000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72625000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79173000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	597000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58519000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58519000	shares
	dei	Document Type DocumentType	10-Q
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	475000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	146979000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	152971000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	165256000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	142347000	usd
CY2023	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2024#AccountingStandardsUpdate201613Member
	us-gaap	Fair Value Asset Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://imetrix.edgar-online.com/20240630#ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44930000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3620000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44930000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3620000	usd
CY2024Q2	twst	Change In Fair Value Of Contingent Consideration And Indemnity Holdback ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback	0	usd
CY2023Q2	twst	Change In Fair Value Of Contingent Consideration And Indemnity Holdback ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback	581000	usd
	twst	Change In Fair Value Of Contingent Consideration And Indemnity Holdback ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback	0	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	170386000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-167047000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11724000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	10472000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	0	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	0	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-422000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-173415000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-157001000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	622000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	656000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1374000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-85571000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-57395000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-174071000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-158375000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-21000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-208000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	56000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1308000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-54000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-538000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-35000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-100000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-85646000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58141000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-174050000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-157167000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.47
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.79
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57041000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57041000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57806000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57806000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56753000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56753000	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	560131000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2915000	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	7000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13746000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-75000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-85571000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	491139000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	703932000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	342000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1014000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1767000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10664000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-746000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-57395000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	657550000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	623432000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5183000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2047000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38642000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21000	usd
	us-gaap	Profit Loss ProfitLoss	-174071000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	491139000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	789385000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	2536000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3275000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5860000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-44930000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3620000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	647000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1040000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38578000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18531000	usd
	twst	Change In Fair Value Of Acquisition Consideration ChangeInFairValueOfAcquisitionConsideration	0	usd
	twst	Change In Fair Value Of Acquisition Consideration ChangeInFairValueOfAcquisitionConsideration	-5913000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	185000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	33000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11398000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2508000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3578000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2949000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	185000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1935000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-472000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1050000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6927000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4431000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4132000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1278000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5932000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	348000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1849000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1799000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-48774000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-121770000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3074000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25386000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	30712000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	58255000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	32000000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	136500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1786000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	52859000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5183000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1208000	usd
	twst	Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan	2536000	usd
	twst	Payments To Repurchases Of Common Stock For Tax Withholding PaymentsToRepurchasesOfCommonStockForTaxWithholding	3967000	usd
	twst	Payments To Repurchases Of Common Stock For Tax Withholding PaymentsToRepurchasesOfCommonStockForTaxWithholding	3275000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3263000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	469000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47244000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-68421000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289281000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	380259000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	242037000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	311838000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	363000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	241000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	226000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1686000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4215000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	5860000	usd
	twst	Tenant Improvement Allowance Acquired Through Property And Equipment Capitalized TenantImprovementAllowanceAcquiredThroughPropertyAndEquipmentCapitalized	2719000	usd
	twst	Tenant Improvement Allowance Acquired Through Property And Equipment Capitalized TenantImprovementAllowanceAcquiredThroughPropertyAndEquipmentCapitalized	0	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	3711000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1207300000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	289400000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239142000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286470000	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2895000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2811000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	242037000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289281000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	700000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2600000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2900000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2800000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3000000.0	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2900000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	600000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2800000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7100000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239142000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	239142000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	3711000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	0	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	0	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	3711000	usd
CY2024Q2	twst	Cash And Cash Equivalents And Short Term Investments Amortized Cost CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost	293158000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	29000	usd
CY2024Q2	twst	Cash Cash Equivalents And Short Term And Long Term Investments CashCashEquivalentsAndShortTermAndLongTermInvestments	293129000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286470000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	286470000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	3711000	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	0	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	0	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	3711000	usd
CY2023Q3	twst	Cash And Cash Equivalents And Short Term Investments Amortized Cost CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost	340210000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	86000	usd
CY2023Q3	twst	Cash Cash Equivalents And Short Term And Long Term Investments CashCashEquivalentsAndShortTermAndLongTermInvestments	340124000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	3711000	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	250400000	usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	0	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	3711000	usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	299308000	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	0	usd
CY2024Q2	us-gaap	Equity Ownership Percentage Excluding Consolidated Entity And Equity Method Investee EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee	0.15
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3700000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3711000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3711000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	22000000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	27024000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2213000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1113000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4271000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3926000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	28484000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	32063000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	176969000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	182486000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70630000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50656000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106339000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131830000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	7000000.0	usd
	us-gaap	Depreciation Depreciation	20900000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	6900000	usd
	us-gaap	Depreciation Depreciation	16800000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	9100000	usd
CY2024Q2	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	9100000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2343000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	4374000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2940000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2999000	usd
CY2024Q2	twst	Other Liabilities Current Other Than Contingent Consideration And Taxes OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes	796000	usd
CY2023Q3	twst	Other Liabilities Current Other Than Contingent Consideration And Taxes OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes	430000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6079000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7803000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	85811000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	85811000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	85811000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	85811000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	66130000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	35864000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15525000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14741000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	66130000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11647000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54483000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	35900000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	35900000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61277000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14555000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72625000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3636000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	14814000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	13885000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8371000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8471000	usd
CY2024Q2	twst	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	88014000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	137191000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	50011000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	87180000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14555000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72625000	usd
	twst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	7500000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	6900000	usd
	twst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	2900000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1900000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	3800000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	11800000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	3700000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	11100000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	3900000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	12200000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	3600000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	11100000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y2M12D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2024Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1700000	usd
CY2023Q2	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1400000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	4500000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	5000000.0	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	600000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1400000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	twst	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1	vote
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2119000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.18
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6715000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	115000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	38.64
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	261000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5123000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1743000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.88
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M28D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47265000	usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	6000	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	106.25
	twst	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P7Y10D
CY2024Q2	twst	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue	0	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1737000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	23.61
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	47265000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	300000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13734000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10598000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38578000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18531000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	-100000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	-500000	usd
CY2023Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	539000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	249000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	124000	shares
CY2024Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	664000	shares
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2024Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2000000.0	usd
CY2023Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2200000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-85571000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-57395000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-174071000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-158375000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58145000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58145000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57041000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57041000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57806000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57806000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56753000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56753000	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.47
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.79
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5658000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4995000	shares
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	81464000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	63740000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	228264000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	178163000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	81464000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	63740000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	228264000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	178163000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	228264000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	178163000	usd
	twst	Intangible Assets Inherit Risk Percentage IntangibleAssetsInheritRiskPercentage	0.14
CY2024Q2	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	9066000	usd
CY2023Q2	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	3620000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	9066000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	3620000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	35864000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	35864000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44930000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3620000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44930000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3620000	usd
CY2023Q2	us-gaap	Restructuring And Related Cost Expected Number Of Positions Eliminated RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated	270	therapeutic
CY2023Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.25
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-034434-index-headers.html	Edgar Link	pending
0001628280-24-034434-index.html	Edgar Link	pending
0001628280-24-034434.txt	Edgar Link	pending
0001628280-24-034434-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
twst-20240630.htm	Edgar Link	pending
twst-20240630.xsd	Edgar Link	pending
twst-20240630x10qxex311.htm	Edgar Link	pending
twst-20240630x10qxex312.htm	Edgar Link	pending
twst-20240630x10qxex321.htm	Edgar Link	pending
twst-20240630x10qxex322.htm	Edgar Link	pending
twst-20240630_g1.jpg	Edgar Link	pending
twst-20240630_def.xml	Edgar Link	unprocessable
twst-20240630_lab.xml	Edgar Link	unprocessable
twst-20240630_pre.xml	Edgar Link	unprocessable
twst-20240630_htm.xml	Edgar Link	completed
twst-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TWST
Twist Bioscience Corp Stock $twst

2024 Q3 Form 10-Q Financial Statement

#000162828024034434 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TWST Twist Bioscience Corp Stock $twst

2024 Q3 Form 10-Q Financial Statement

#000162828024034434 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TWST
Twist Bioscience Corp Stock $twst